For example, because of their chain-selective fibrinogen-degrading activity, kallikrein enzymes from snake venom have been used as anticoagulant treatment of stroke, heart attack, and deep-vein thrombosis [85,127]. This evidence concerns the gene KLK4 and Stroke.